Abstract
Purpose
The kidney plays a central physiologic role as an oxygen sensor. Nevertheless, the direct mechanism by which this occurs is incompletely understood. We measured renal microvascular partial pressure of oxygen (PkO2) to determine the impact of clinically relevant conditions that acutely change PkO2 including hyperoxia and hemodilution.
Methods
We utilized two-wavelength excitation (red and blue spectrum) of the intravascular phosphorescent oxygen sensitive probe Oxyphor PdG4 to measure renal tissue PO2 in anesthetized rats (2% isoflurane, n = 6) under two conditions of altered arterial blood oxygen content (CaO2): 1) hyperoxia (fractional inspired oxygen 21%, 30%, and 50%) and 2) acute hemodilutional anemia (baseline, 25% and 50% acute hemodilution). The mean arterial blood pressure (MAP), rectal temperature, arterial blood gases (ABGs), and chemistry (radiometer) were measured under each condition. Blue and red light enabled measurement of PkO2 in the superficial renal cortex and deeper cortical and medullary tissue, respectively.
Results
PkO2 was higher in the superficial renal cortex (~ 60 mmHg, blue light) relative to the deeper renal cortex and outer medulla (~ 45 mmHg, red light). Hyperoxia resulted in a proportional increase in PkO2 values while hemodilution decreased microvascular PkO2 in a linear manner in both superficial and deeper regions of the kidney. In both cases (blue and red light), PkO2 correlated with CaO2 but not with MAP.
Conclusion
The observed linear relationship between CaO2 and PkO2 shows the biological function of the kidney as a quantitative sensor of anemic hypoxia and hyperoxia. A better understanding of the impact of changes in PkO2 may inform clinical practices to improve renal oxygen delivery and prevent acute kidney injury.
Résumé
Objectif
Les reins jouent un rôle physiologique central en tant que détecteurs d’oxygène. Cependant, le mécanisme direct de ce rôle n’est pas complètement compris. Nous avons mesuré la pression partielle d’oxygène microvasculaire rénal (PkO2) afin de déterminer l’impact de conditions pertinentes d’un point de vue clinique qui modifient de façon aiguë la PkO2, y compris l’hyperoxie et l’hémodilution.
Méthode
Nous avons utilisé l’excitation à deux longueurs d’onde (spectres rouge et bleu) de la sonde phosphorescente, sensible à l’oxygène, intravasculaire Oxyphor PdG4 afin de mesurer la PO2 dans le tissu rénal de rats sous anesthésie (isoflurane 2 %, n = 6) dans deux conditions de contenu en oxygène du sang artériel (CaO2) altéré : 1) hyperoxie (fraction d’oxygène inspiré 21 %, 30 % et 50 %) et 2) anémie par hémodilution aiguë (valeurs de base, hémodilution aiguë 25 % et 50 %). La tension artérielle moyenne (TAM), la température rectale, les gaz sanguins artériels et la chimie (radiomètre) ont été mesurés dans chacune des conditions. Les lumières bleue et rouge ont permis de mesurer la PkO2 dans le cortex rénal superficiel et les tissus cortical et médullaire plus profonds, respectivement.
Résultats
La PkO2 était plus élevée dans le cortex rénal superficiel (~ 60 mmHg, lumière bleue) comparativement au cortex rénal plus profond et à la zone médullaire extérieure (~ 45 mmHg, lumière rouge). L’hyperoxie a entraîné une augmentation proportionnelle des valeurs de PkO2, alors que l’hémodilution a diminué la PkO2 microvasculaire de façon linéaire tant dans les régions rénales superficielles que plus profondes. Dans les deux cas (lumières bleue et rouge), la PkO2 était corrélée au CaO2 mais pas à la TAM.
Conclusion
La relation linéaire observée entre le CaO2 et la PkO2 montre la fonction biologique du rein en tant que détecteur quantitatif de l’hypoxie anémique et de l’hyperoxie. Une meilleure compréhension de l’impact des changements de la PkO2 pourrait guider les pratiques cliniques afin d’améliorer la distribution d’oxygène aux reins et prévenir l’insuffisance rénale aiguë.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The kidney is the body’s chief “blood oxygen content sensor”. This contributes to its roles as a regulator of integrated physiologic responses to anemia1 and the major source of systemic erythropoietin (EPO) production.2,3,4 Nevertheless, our understanding of the mechanisms by which it achieves this function remains incomplete. We, and others, have provided evidence that the kidney accurately senses blood oxygen content (CaO2) and converts this signal into a detectable level of microvascular kidney partial pressure of oxygen (PkO2).2,5,6,7 This mechanism allows cells within the kidney to respond to a specific microvascular PkO2 as renal and systemic oxygen delivery change under varying conditions. In addition, this mechanism allows local cells to respond and alter expression of hypoxia-inducible genes, including those that synthesize EPO.3,4 Furthermore, this detection of PkO2 may also trigger afferent signals, via the renal nerves, to initiate additional adaptive integrative physiologic changes that maintain overall oxygen homeostasis.1 One of the important concepts regarding tissue oxygen sensing is that, while oxygen is not the most soluble of biological gases, it nevertheless travels rapidly down concentration gradients across tissues and into cells.8,9 As such, oxygen is not impacted by anatomical divisions within organs; it does not differentiate between renal cortex or medulla, other than by local aspects of metabolic supply (perfusion) and demand (cellular metabolic requirement) and by vascular anatomy.10,11,12
The anatomy and physiology of the kidney reflect its multiple functions including waste removal, fluid and electrolyte homeostasis, and erythrogenesis. To perform these functions, the kidney receives 25% of the cardiac output and consumes about 20% of global oxygen delivery. The functional unit of the kidney is the nephron, largely defined by the filtering glomeruli, the reabsorbing and secreting tubules and vascularization by a complex blood supply. Active resorption of vital nutrients, including sodium, is a function of the cortex (proximal convoluted tubule) and outer medulla (thick ascending loop of Henle). Water resorption is largely a function of the strong sodium concentration gradient established in the medulla. Among the multiple endocrine functions of the kidney, erythrogenesis is regulated by hypoxic induction of EPO production and secretion from cells strategically located near the cortical medullary junction.13,14
In the current study, we utilized a dual light wavelength approach to measuring superficial cortical (blue light) and deeper renal cortical and medullary PkO2 (red light) under different conditions of renal oxygen delivery, using phosphorescence quenching. We hypothesized that the physiology of renal oxygenation is set up in such a way that PkO2 is dependent on CaO2 and that both superficial and deeper renal PkO2 would be different in response to changes in CaO2 induced by hyperoxia (which increases CaO2) and hemodilutional anemia (which decreases CaO2).
Methods
Animal model
All experimental protocols were approved by the Animal Care and Use Committee at St. Michael’s Hospital (Toronto, ON, Canada) and conducted in accordance with the Canadian Council on Animal Care and ARRIVE-2 guidelines. Male Sprague Dawley rats (Charles River) were utilized for the experiments (n = 6; body weight = 400–500 g). Animals were housed in groups of two in standard research cages with species-appropriate enrichment. They had access to food and water ad libitum in a pathogen-free facility with a 12:12 hr light-dark cycle. After arrival to the research facility, the rats were allowed a one-week acclimation period before experiments were performed.
In spontaneously breathing rats, anesthesia was induced within an inhalation chamber with 4% isoflurane. Anesthesia was then maintained via tracheostomy with 1.5–2.0% isoflurane, initially in 21% O2 at a total flow rate of 2 L·min−1 The tail vein and tail artery were cannulated to allow infusion of the hemodilution solutions, measurement of mean arterial pressure (MAP), and drawing of arterial blood for blood oximetry and chemistry (ABL 800 Flex, Radiometer Canada, London, ON, Canada). Heart rate (HR) was measured with electrocardiogram electrodes and the rectal temperature was monitored. A thermoregulatory heating pad was used to maintain rectal temperatures near 37 °C. A computerized data-acquisition system (PowerLab AD Instruments Inc., Colorado Springs, CO, USA) was used to continually monitor MAP, HR, and rectal temperature.
Hyperoxia protocol
Rats underwent spontaneous ventilation at three levels of fractional inspired oxygen (FIO2): 21% (baseline), 30%, and 50%, for 20 min each. At each level of inspired oxygen, three one-minute periods of measurement of microvascular PkO2 were performed in sequence utilizing: 1) red wavelength light-emitting diode (LED, λmax = 635 nm); 2) blue wavelength LED (λmax = 450 nm) and finally; 3) red laser light (λmax = 635 nm), according to the methods outlined below. Arterial blood gases (ABGs) were measured at the end of each period prior to changing the FIO2. At the end of this experiment, the FIO2 was returned to baseline (21%) and animals were allowed to re-equilibrate for 30 min before initiating the hemodilution protocol.
Hemodilution protocol
After re-establishing baseline conditions, a baseline ABG was taken prior to the first stage of hemodilution. Rats underwent hemodilution by replacing 25% of the estimated blood volume with hydroxyethyl starch 6% (Voluven 130/0.4, Fresnius Kabi, Toronto, ON, Canada). Hemodilution was performed with a push-pull infusion pump (PHD2000, Harvard Apparatus, St. Laurent, QC, Canada) to maintain a steady hemodilution rate over the ten-minute period. All fluids were warmed to 37 °C before administration. After hemodilution, arterial blood was collected for analysis of oximetry and chemistry (ABG, radiometer) into heparinized syringes. Following hemodilution, microvascular PkO2 was measured by alternating sequentially to three different light sources in the following order: red LED then blue LED then red laser. Arterial blood oximetry and chemistry were assessed as described for the hyperoxia protocol. Subsequently, a second 25% hemodilution was performed (total 50%) and then PkO2 and arterial blood oximetry and chemistry were re-assessed. At the end of each experiment, animals were euthanized by isoflurane overdose and intravascular injection of T-61 euthanasia solution.
Microvascular kidney oxygen measurements (PkO2)
Microvascular kidney PkO2 was measured in the left kidney using the phosphorescence quenching method. The intravascular oxygen probe Oxyphor PdG4 was deployed in combination with a time-domain OxyLED phosphorometer (Oxygen Enterprises Ltd., Philadelphia, PA, USA).8,15 We utilized an oximeter (OxyLED) capable of generating light at 450 nm (blue) and 635 nm (red) to excite the Soret and the Q-bands of the tetrabenzoporphyrin at the core of the probe, respectively. A common light detector was utilized to detect emitted phosphorescence following probe excitation with either blue or red light. This methodology was initially developed by Rumsey et al.7 and adapted by Johannes et al.5 to utilize excitation of phosphorescence of PdG2 (spectroscopically identical to PdG4)15 using blue and red light to discriminate between the PkO2 measurements in the superficial renal cortex (blue light) and deeper renal cortical and medullary tissue (red light) (Fig. 1). The left kidney was exposed via a dorsal flank incision and the subjacent soft tissue and peri-renal fat were retracted. The kidney was kept within the retroperitoneal space and in the body cavity to maintain the renal temperature comparable to the core temperature. The animal was kept in a hooded experimental chamber to prevent ambient light from interfering with the measurements.
Light excitation and detection
Excitation light was delivered from three different sources: 1) a red LED (λmax=635 nm), the output of which was focused on an area of ~3.0 mm diameter on the cortical surface; 2) a blue LED, (λmax = 450 nm), the output of which was focused on an area of ~ 3.0 mm diameter, and 3) a red laser (λmax =635 nm), the output of which was focused on an area ~0.1 mm in diameter. At the red wavelength, light penetration is expected to exert its maximal energy at a depth of 1–2 mm and have some degree of excitation as deep as 3–4 mm with significant signal attenuation in proportion to the depth of tissue penetration. Thus, light measurements are taken from the microvasculature within the entire renal cortex (~ 2 mm) and the underlying superficial medulla. The intensity of the red laser is higher than that of the red LED and its beam is more tightly focused. Nevertheless, as the light wavelength and O2 detection methods are similar, these methods are expected to produce comparable values. By contrast, at the blue wavelength, the depth of light penetration is expected to be attenuated to less than 1 mm, thus providing a measurement that is essentially contained within the microcirculation of the superficial renal cortex (Fig. 1). We performed sequential measurement over the same kidney region utilizing the red LED followed by the blue LED by switching the light source through the same excitation light guide, and then conducted measurements with the red laser, with the beam targeted to the centre of the broader LED light beam. The second red laser measurements served as a positive control for the first red LED measure and bracketed the blue light measurement.
For all three excitation lights, the emission detecting light guide was positioned 1–2 mm directly above the focus of excitation and received input from the tissue at a wavelength of 813 nm. Typically, 200 data collection cycles were averaged in a single measurement (two milliseconds), and the measurements were performed at one-second intervals. Experimental conditions were deemed acceptable with a signal to noise ratio of phosphorescence decay of greater than 2.
Intravascular oxygen sensing probe
Prior to commencing PkO2 measurements, Oxyphor PdG4 was injected intravenously (450 µL of ~ 25 µM solution in saline) to reach a final concentration in the blood plasma of ~2 µM. The excitation light at 635 and 450 nm is relatively weakly absorbed by the endogenous tissue chromophores (e.g., hemoglobin, cytochromes, etc.). The phosphorescence of Oxyphor PdG4 (λmax = 813 nm) is attenuated by endogenous absorption even less than the excitation light, but the emitted photons generated at depths have to diffuse back to the surface to be sensed by the detector. As a result, the volume of tissue probed in such a surface excitation/emission scheme does not have strictly defined borders, although it does vary with the light transport coefficients at the wavelengths specified. It is reasonable to assume that the recorded signals are dominated by the phosphorescence originating in the upper 1–4 mm of tissue with tissue layers closer to the surface giving larger contribution to the signal (red light). By contrast, the recorded signals are predominantly derived from phosphorescence originating in the upper < 1 mm of tissue for the blue light measurements. Thus, the measurements performed in this study carry information chiefly about microvascular PkO2 within the combined renal cortex and superficial medullary tissue (red light) or conversely from the superficial renal cortex alone (blue light).
Sample size calculation
The sample size was calculated for the primary outcome of change in PkO2 based on preliminary data from previous experiments2 and in accordance with the ARRIVE-2 guidelines emphasizing the goal of refining the experimental protocol to reduce animal numbers required. We estimated an expected PkO2 difference between high and low O2 (21% and 50% FIO2) and baseline vs 50% hemodilution FIO2 to be ~ 20 mmHg in each case from baseline (increased in the former and decreased in the latter). Estimating a standard deviation of 5.0, and assuming a power of 0.8 and an alpha of 0.05, our predicted sample size was six animals for each study. As a brief exposure to 30 and 50% FIO2 was not expected to have a long-term impact on oxygen delivery or tissue oxygenation, we utilized the same animal for both protocols to minimize the number of animals required for these studies. Because there was a single experimental protocol, no blinding was performed.
Outcome measures
Measured outcomes in all animals include PkO2 (measured with red LED, blue LED, and red laser), MAP, rectal temperature, ABG analyses and co-oximetry (pH, arterial pressure of carbon dioxide (PaCO2), arterial partial pressure of oxygen (PaO2), bicarbonate (HCO3), hemoglobin (Hb), arterial blood oxygen saturation (SaO2), and CaO2), and arterial electrolyte concentration (sodium, chloride, potassium, calcium, glucose, and lactate), all during hyperoxia and hemodilution.
Statistical analysis
Normality was tested with the Shapiro–Wilk test. Data that did not significantly violate normality were subjected to two-way analysis of variance (ANOVA) for repeated measures and post-hoc Tukey test for pairwise comparisons. Data that failed the Shapiro–Wilk test were analyzed using the Kruskal–Wallis one-way ANOVA on ranks followed by post-hoc pairwise comparisons using Dunn’s method. Lines of best fit were generated by ordinary least products regression analysis. Analysis of covariance was used to determine whether these relationships differed according to the intervention (hyperoxia or hemodilution). A two-tailed P < 0.05 was considered statistically significant. Analyses were performed using either Sigmaplot or Systat software (Systat Software Inc., San Jose, CA, USA).
Results
Physiologic parameters
Following stepwise increases in FIO2 (hyperoxia), there were no changes in HR or MAP (Fig. 2, panels A and B). Following hemodilution, there was a significant increase in HR after 25% and 50% hemodilution, relative to baseline (Fig. 3, panel A). No statistically significant changes were observed in the MAP; however, there was a trend for MAP to decrease after 50% hemodilution (Fig. 3, panel B). Rectal temperature remained stable, near 37 °C throughout the experimental period.
Arterial blood gas analysis
The blood oximetry data showed the expected changes in PaO2, Hb, and CaO2 during hyperoxia and hemodilution (Tables 1 and 2). With increasing FIO2, there was an expected stepwise increase in PaO2 and arterial blood Hb saturation (SaO2), and a slight increase in CaO2, as dictated by the formula: CaO2 = (1.34 * Hb * SaO2/100) + (0.0031 * PaO2) (P < 0.05). All other parameters did not change as FIO2 increased from 21% to 30% to 50% (Table 1). Following hemodilution, there was an expectant stepwise decrease in blood hemoglobin concentration and CaO2 (P < 0.001). As hydroxyethyl starch is constituted in 0.9% w/v NaCl, an increase in plasma chloride concentration was observed (P = 0.025); plasma HCO3 decreased (P = 0.03) and lactate increased slightly after 50% hemodilution (P = 0.006) (Table 2). Serum glucose decreased after hyperoxia and 50% hemodilution (P < 0.05) There were no statistically significant differences in other parameters over time (Table 2).
Kidney microvascular PkO2 values
At baseline, the PkO2 values obtained with the red light (LED, laser) were comparable to those reported previously1 (Figs 2 and 3, panel C). In all conditions, the PkO2 values obtained with the blue light were higher than those generated using red light (Figs 2 and 3). In all cases, the microvascular renal PkO2 values were comparable when taken using the red LED, prior to blue LED measurement, and those of the red laser which were taken immediately after the blue LED measurement. This sequence showed the stability of the red light measurements and that the PkO2 values were comparable when measured using excitation red light delivered by differing light intensities and beam widths.
During hyperoxia exposure, renal kidney tissue PkO2 increased with each increase in the level of FIO2 as measured following oxyphor excitation by both red and blue light (Fig. 2, panel C). During sequential hemodilution, the PkO2 decreased in proportion to the reduction in blood hemoglobin concentration and CaO2, in a stepwise manner, despite a relatively constant PaO2 (Fig. 3, panel C). The red LED and laser values were comparable when measured before and after the blue LED values.
Assessment of different correlations between physiologic parameters showed that renal microvascular PkO2, measured with blue or red light, did not correlate with MAP (r2 = 0.08 and 0.005, respectively) (Fig. 4, panels A). Nevertheless, values for microvascular renal PkO2 obtained with blue vs red LED were closely correlated (r2 = 0.78) (Fig. 4, panel B).
Assessment of the relationships between microvascular renal PkO2 utilizing blue and red light showed significant correlations with CaO2 (Fig. 5). PkO2 was closely correlated with CaO2 both for blue (r2 = 0.56) and red (r2 = 0.69) light, representing measurements from the superficial renal cortex and deep renal cortex and outer medulla, respectively. The relationships between these variables did not vary significantly between the two interventions (Fig. 5).
We hypothesized that a change in CaO2 with hemodilution would follow a different relationship than hyperoxia. Nevertheless, our analysis failed to detect any significant differences. Therefore, while there is a difference between red and blue light, we found a linear relationship between hyperoxia and hemodilution. We ran the regression analyses for the individual interventions, and found the following results for hyperoxia (red LED r2 = 0.232, P = 0.07, blue LED r2 = 0.343, P = 0.02, red laser r2 = 0.051, P = 0.42) and for hemodilution (red LED r2 = 0.687, P < 0.001, blue LED r2 = 0.469, P = 0.005, red laser r2 = 0.847, P < 0.001). Thus, as predicted by the data in the scatterplots, the relationships were more robust for hemodilution than for hyperoxia. Nevertheless, a significant relationship was observed for hyperoxia with the blue LED and a strong tendency was seen with the red LED.
Discussion
We show that PkO2, in both superficial and deeper layers of the kidney, varies in a linear manner with CaO2. Importantly, a single relationship can adequately explain the variation of PkO2 with CaO2 during hyperoxia and hemodilution. This allows us to attribute the oxygen sensing capacity of the kidney to an ability to translate changes in CaO2 to changes in kidney PkO2. The impact of hyperoxia (relatively high CaO2) and anemia (low CaO2) on changes in PkO2 showed a similar linear relationship, supporting the hypothesis that CaO2 is biologically sensed. The lack of correlation between MAP and arterial PaO2 and renal microvascular PkO2 supports the finding that CaO2 is an important physiologic parameter that regulates renal PkO2.
Our observations are in accord with traditional studies assessing increased expression of renal EPO following exposure to both hypoxia and anemia.3,4 Recent observations in humans regarding the control of EPO release from the kidney support the concept that CaO2 and not PaO2 is the important variable with respect to regulating EPO secretion.16 In a crossover study with human volunteers, Montero and Lundby showed that the increase in systemic EPO levels associated with a reduction of CaO2 induced by subjects breathing low concentrations of carbon monoxide while mainlining PaO2 above 100 mmHg was comparable to that observed by reduced CaO2 induced by breaking a hypoxic gas mixture (FIO2 = 11%). Thus, the mechanisms that regulate kidney oxygenation appear to be set up in such a way that microvascular, and thus tissue PO2, is sensitive to changes in CaO2 no matter how they are induced.16
The dominance of CaO2 in the control of renal tissue oxygenation can be explained by available knowledge regarding oxygen transport to tissue and the incorporation of this knowledge into computational models of renal oxygen transport. It is well established that oxygen delivery to tissue is driven by the gradient between the intravascular and tissue PO2.17 Importantly, in the kidney18 and in other vascular beds,17 oxygen diffuses from the vasculature to the tissue not only from capillaries but also from arterial vessels. Consequently, as blood flows from the main renal artery to the renal microvasculature, its oxygen content falls in proportion to the gradient between the vascular and tissue compartments.19 Some oxygen is also lost via diffusion to the veins, which are often closely associated with the arterial vessels.19,20
Factors driving renal oxygen delivery include CaO2 and dissolved O2. The formula for CaO2 further defines the relationship between Hb-bound O2 and dissolved O2 in the plasma: CaO2 = (1.34 × Hb × SaO2/100) + (0.0031 × PaO2). This formula expresses that PaO2 (i.e., dissolved oxygen in plasma) only represents a minute portion of the total oxygen transported in the blood. Simplistically, oxygen carried by Hb represents the bulk of O2 delivered to tissues while arterial PaO2 and microvascular renal PkO2, represent the component of oxygen progressively released from Hb on route to the mitochondria of metabolically active cells. The complexity of local renal vascular–tissue oxygen gradients are not directly measured by our technique; rather, the sum effect of these local oxygen gradients are measured within a sample of renal microvasculature that directly reflects tissue PO2.2
Simulations derived from computational models of oxygen transport predict that, under conditions where there is an increase in the fraction of inspired O2, arterial PO2 falls rapidly along the arterial tree because this condition is associated with only a small additional quantity of oxygen in the blood. Consequently, the increase in CaO2 (~ 15%) and PkO2 (~ 25%) observed with hyperoxia are relatively small in relation to the increase in PaO2 (~ 250%). Nevertheless, the changes in CaO2 remain in proportion to the changes in renal microvascular PkO2.21,22 On the other hand, when CaO2 is reduced by hemodilution by decreasing the major determinant of CaO2 (i.e., Hb), blood oxygen content is reduced by a larger proportion (~ 60%) as reflected by a more pronounced drop in kidney PkO2 (~ 50%). Under these conditions, oxygen diffusion from the arterial tree results in a more pronounced reduction in the PO2 of blood, as it flows to the microvasculature, compared with normal conditions.23 As we show herein, the change in PkO2 is proportional to the change in CaO2. The consequence of this physiologic system is that the EPO-producing cells in the kidney are in an ideal place to sense changes in CaO2 and thus regulate red cell production in response to acute anemia.2,3,4,13,14
Our findings are also consistent with the notion of a gradient in microvascular and tissue PO2 from the renal cortex to medulla,24 at least in anesthetized animals5,25,26 and humans.27,28 This gradient may be less pronounced in the absence of anesthesia.29 In the current study of anesthetized rats, we found PkO2 measured using a red LED was systematically lower than that measured using a blue LED, likely because the red LED penetrates deeper into the tissue.30 Nevertheless, changes in CaO2 resulted in proportionally similar changes in the two measures of microvascular PkO2. We are not aware of any previous direct quantitative comparison of the relative sensitivities of kidney tissue, at various depths below the cortical surface, to changes in CaO2. Nevertheless, our current findings are consistent with the observation of similar changes in renal cortical and medullary PkO2 induced by hemodilution in rats,5 hypoxia in rabbits,31 and hyperoxia in sheep.29
Understanding the relationship between the physiologic function of the kidney with respect to oxygen demand and supply may help explain its role as an oxygen sensor. With respect to metabolic demand, we will focus on sodium (Na) resorption as one of the major components of renal metabolic demand.14 The majority of filtered Na (~ 65%) is recovered in the proximal convoluted tubule within the renal cortex, powered by the sodium potassium ATPase. The next important component for Na resorption (~ 25%) occurs in the loop of Henle within the renal medulla. About half of medullary Na resorption occurs passively, along the generated concentration gradient, while the remaining half is absorbed via active transport in the thick ascending limb of Henle’s loop (Na-K ATPase). The remaining 10% of Na resorption occurs by active transport in the distal convoluted tubule, situated adjacent to the macula densa of the glomerulus.
To optimize renal oxygen delivery, the vasculatures of the renal cortex and medulla are arranged in parallel, starting at the level of the proximal interlobular arteries. Thus, blood flow to these two vascular territories can be independently regulated. In the outer medulla, the blood supply further divides as some vasa recta capillaries form a plexus in the outer medulla while others go on to perfuse the inner medulla. Thus, there is some potential for independent regulation of perfusion of the inner and outer medulla.20
Finally, the balance of oxygen supply and demand dictate how the kidney functions as an oxygen sensor.14 The kidney is the principal regulator of erythrocyte production as a response to vascular oxygen content induced by hypoxia or anemia.2,3,4,32,33 Under resting conditions, the majority of EPO-producing cells are located near the cortico-medullary junction.3,4 Nevertheless, following exposure to conditions that cause renal tissue hypoxia or molecular manipulation to simulate hypoxia, the regions in which EPO-producing cells are identified expands into the superficial renal cortex and deep medulla,4,13,34 thereby showing the capacity for rapid and profound upregulation of EPO transcription and excretion.
By utilizing characteristics of shorter wavelength blue light vs longer wavelength red light, we have observed that measurements of PkO2 are higher in the superficial renal cortex (blue light) than values obtained with more deeply penetrating red light. This finding has been previously reported utilizing stepwise progression of Clarke type microelectrodes6 and utilizing the method of phosphorescence quenching during acute hemodilution.5 Nevertheless, a clear relationship between CaO2 and PkO2 was not derived by these previous studies. The difference in the values measured with blue vs red light suggest that superficial blue light measures more arterialized blood from afferent arterioles as they enter the glomeruli, situated in the cortex. Conversely, red light penetrates more deeply into the renal cortex and outer renal medulla. Furthermore, the renal cortex and outer renal medulla are highly metabolic because of the metabolic activity of the proximal convoluted tubule and thick ascending loop of Henle, which both consume high amounts of oxygen. This is one of the multiple explanations for a decreased PkO2 in the outer medulla compared with the cortex.11 The finding that PkO2 values with blue and red light strongly correlate with one another suggests that measurement of superficial cortical or deeper cortical and medullary microvascular PkO2 both reflect changes in blood CaO2, in balance with local oxygen demand. The net effect reflects the balance between oxygen supply and demand.
Estimates of renal oxygen consumption and metabolic activity suggest that the proximal tubules and outer medullary thick ascending loop of Henle (mTAL) represent regions of high metabolic oxygen requirement.35,36 Furthermore, the inner renal cortex and outer renal medulla are the locations for EPO synthesis3,4 while the outer medulla is the region of the kidney most susceptible to hypoxia, in part due to relatively limited vascular supply compared with the cortex.11,20 The disposition of the medullary vasculature (the vasa recta) in bundles leads to countercurrent oxygen exchange throughout the medulla. This results in a decreased oxygen supply in the inner renal medulla. The disposition of the vascular bundles, with respect to the mTAL and the collecting duct, results in an oxygen gradient from the bundles to these elements of the nephron, rendering them especially susceptible to hypoxia.11,20 Therefore, the renal outer medulla is at particular risk of hypoxia and hypoxic injury, as the balance of oxygen supply and demand puts this region at risk of inadequate oxygen delivery.35,37 This characteristic is precisely what renders it an efficient sentinel for the oxygenation status of the rest of the body. In fact, the medullary region is known for its capacity to rapidly upregulate hypoxia gene expression,2,4 including EPO, showing the link between low CaO2, microvascular PkO2, and hypoxic biological responses.
Translational implications
We have previously shown that experimental measurement of tissue oxygen tension can inform clinical decision-making in a number of clinical scenarios. For example: 1) anemia is associated with tissue hypoxia,38 possibly explaining the association between preoperative anemia and increased mortality39; 2) systemic β-blockade accentuates anemia-induced cerebral hypoxia,40,41,42 possibly explaining the increased incidence of perioperative stroke43; 3) acute anemia worsens brain tissue hypoxia and greatly enhances the degree of brain injury,44 supporting utilization of brain PO2 monitoring to support clinical decision-making45 and potentially improving patient outcomes46; and 4) assessment of renal PkO2 showed a more profound decrease following hemodilution with starch vs albumin or saline,2 possibly providing a mechanistic explanation for increased renal toxicity associated with starch-based fluid resuscitation in critical care settings.47 The current study shows that microvascular renal PO2 values reflect oxygen delivery to tissues at times of reduced blood oxygen content. Clinical studies have attempted to measure renal tissue hypoxia may predict adverse outcomes, including acute kidney injury.28,48 The common goal of these approaches is to direct therapies to reduce perioperative organ injury and adverse clinical outcomes.
Limitations
There are some limitations to our current study. First, we did not measure cardiac output (CO) in this experimental data set as we have previously showed that CO increases following hemodilution with starch,2,42 but that changes in microvascular renal perfusion are not directly liked to these changes in CO.2 Second, the effect of hyperoxia was limited because of the small increment in CaO2 (PaO2 only contributes to a small proportion of total CaO2). Nevertheless, the slope of the hyperoxia effect was comparable to that of hemodilution, supporting that the impact of both hyperoxia and hemodilution were influenced by CaO2. Third, these measurements were performed under anesthesia, which is known to impact renal oxygen delivery.23 Indeed, increased FIO2 and hyperoxia have been shown to restore renal oxygen tension in experimental models potentially supporting the use of hyperoxia in patients under general anesthesia to preserve renal function.
Perspectives and significance
Utilizing non-invasive methods to measure microvascular renal tissue PkO2, we have shown a linear relationship between blood oxygen content (CaO2) and renal tissue PkO2. The relationship is maintained with two different excitation light wavelengths, confirming the impact of CaO2 in superficial (with blue light) and deeper (with red light) renal tissue. These data provide an experimental means for assessing the impact of tissue hypoxia on renal injury28,48 and the impact of strategies to mitigate such injury.
References
Hare GM, Tsui AK, Ozawa S, Shander A. Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol 2013; 27: 85-98.
Abrahamson JR, Read A, Chin K, et al. Renal tissue PO2 sensing during acute hemodilution is dependent on the diluent. Am J Physiol Regul Integr Comp Physiol 2020; 318: R799-812.
Eckardt KU, Koury ST, Tan CC, et al. Distribution of erythropoietin producing cells in rat kidneys during hypoxic hypoxia. Kidney Int 1993; 43: 815-23.
Koury ST, Koury MJ, Bondurant MC, Caro J, Graber SE. Quantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentration. Blood 1989; 74: 645-51.
Johannes T, Mik EG, Nohe B, Unertl KE, Ince C. Acute decrease in renal microvascular PO2 during acute normovolemic hemodilution. Am J Physiol Renal Physiol 2007; 292: F796-803.
Lubbers DW, Baumgartl H. Heterogeneities and profiles of oxygen pressure in brain and kidney as examples of the pO2 distribution in the living tissue. Kidney Int 1997; 51: 372-80.
Rumsey WL, Abbott B, Lo LW, Vinogradov SA, Wilson DF. Imaging of oxygen distribution in the surface and deep areas of the kidney. Adv Exp Med Biol 1997; 411: 591-5.
Esipova TV, Barrett MJ, Erlebach E, Masunov AE, Weber B, Vinogradov SA. Oxyphor 2P: a high-performance probe for deep-tissue longitudinal oxygen imaging. Cell Metab 2019; 29(736–44): e7.
Wilson DF, Lee WM, Makonnen S, Finikova O, Apreleva S, Vinogradov SA. Oxygen pressures in the interstitial space and their relationship to those in the blood plasma in resting skeletal muscle. J Appl Physiol 1985; 2006(101): 1648-56.
Evans RG, Iguchi N, Cochrane AD, et al. Renal hemodynamics and oxygenation during experimental cardiopulmonary bypass in sheep under total intravenous anesthesia. Am J Physiol Regul Integr Comp Physiol 2020; 318: R206-13.
Evans RG, Smith DW, Lee CJ, Ngo JP, Gardiner BS. What Makes the Kidney Susceptible to Hypoxia? Anat Rec (Hoboken) 2019. DOI: https://doi.org/10.1002/ar.24260.
Gardiner BS, Smith DW, Lee CJ, Ngo JP, Evans RG. Renal oxygenation: from data to insight. Acta Physiol (Oxf) 2020. DOI: https://doi.org/10.1111/apha.13450.
Gerl K, Nolan KA, Karger C, et al. Erythropoietin production by PDGFR-β(+) cells. Pflugers Arch 2016; 468: 1479-87.
Halperin ML, Cheema-Dhadli S, Lin SH, Kamel KS. Properties permitting the renal cortex to be the oxygen sensor for the release of erythropoietin: clinical implications. Clin J Am Soc Nephrol 2006; 1: 1049-53.
Esipova TV, Karagodov A, Miller J, Wilson DF, Busch TM, Vinogradov SA. Two new “protected” oxyphors for biological oximetry: properties and application in tumor imaging. Anal Chem 2011; 83: 8756-65.
Montero D, Lundby C. Arterial oxygen content regulates plasma erythropoietin independent of arterial oxygen tension: a blinded crossover study. Kidney Int 2019; 95: 173-7.
Pittman RN. Oxygen transport in the microcirculation and its regulation. Microcirculation 2013; 20: 117-37.
Olgac U, Kurtcuoglu V. Renal oxygenation: preglomerular vasculature is an unlikely contributor to renal oxygen shunting. Am J Physiol Renal Physiol 2015; 308: F671-88.
Lee CJ, Ngo JP, Kar S, Gardiner BS, Evans RG, Smith DW. A pseudo-three-dimensional model for quantification of oxygen diffusion from preglomerular arteries to renal tissue and renal venous blood. Am J Physiol Renal Physiol 2017; 313: F237-53.
Evans RG, Eppel GA, Anderson WP, Denton KM. Mechanisms underlying the differential control of blood flow in the renal medulla and cortex. J Hypertens 2004; 22: 1439-51.
Lee CJ, Gardiner BS, Evans RG, Smith DW. A model of oxygen transport in the rat renal medulla. Am J Physiol Renal Physiol 2018; 315: F1787-811.
Lee CJ, Gardiner BS, Ngo JP, Kar S, Evans RG, Smith DW. Accounting for oxygen in the renal cortex: a computational study of factors that predispose the cortex to hypoxia. Am J Physiol Renal Physiol 2017; 313: F218-36.
Lee CJ, Smith DW, Gardiner BS, Evans RG. Stimulation of erythropoietin release by hypoxia and hypoxemia: similar but different. Kidney Int 2019; 95: 23-5.
Wenger RH, Hoogewijs D. Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells. Am J Physiol Renal Physiol 2010; 298: F1287-96.
Baumgärtl H, Leichtweiss HP, Lübbers DW, Weiss C, Huland H. The oxygen supply of the dog kidney: measurements of intrarenal pO 2. Microvas Res 1972; 4: 247-57.
Leichtweiss HP, Lübbers DW, Weiss C, Baumgärtl H, Reschke W. The oxygen supply of the rat kidney: measurements of int4arenal pO2. Pflugers Arch 1969; 309: 328-49.
Leonhardt KO, Landes RR. Oxygen tension of the urine and renal structures. Preliminary report of clinical findings. N Engl J Med 1963; 269: 115-21.
Zhu MZ, Martin A, Cochrane AD, et al. Urinary hypoxia: an intraoperative marker of risk of cardiac surgery-associated acute kidney injury. Nephrol Dial Transplant 2018; 33: 2191-201.
Iguchi N, Kosaka J, Iguchi Y, et al. Systemic haemodynamic, renal perfusion and renal oxygenation responses to changes in inspired oxygen fraction during total intravenous and volatile anesthesia. Br J Anaesth 2020; 125: 192-200.
Ash C, Dubec M, Donne K, Bashford T. Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med Sci 2017; 32: 1909-18.
Evans RG, Goddard D, Eppel GA, O’Connor PM. Factors that render the kidney susceptible to tissue hypoxia in hypoxemia. Am J Physiol Regul Integr Comp Physiol 2011; 300: R931-40.
Mistry N, Mazer CD, Sled JG, et al. Red blood cell antibody-induced anemia causes differential degrees of tissue hypoxia in kidney and brain. Am J Physiol Regul Integr Comp Physiol 2018; 314: R611-22.
Weidemann A, Johnson RS. Nonrenal regulation of EPO synthesis. Kidney Int 2009; 75: 682-8.
Souma T, Suzuki N, Yamamoto M. Renal erythropoietin-producing cells in health and disease. Front Physiol 2015. DOI: https://doi.org/10.3389/fphys.2015.00167.
Kim N, Voicu L, Hare GM, et al. Response of the renal inner medulla to hypoxia: possible defense mechanisms. Nephron Physiol 2012; 121: 1-7.
Layton AT, Laghmani K, Vallon V, Edwards A. Solute transport and oxygen consumption along the nephrons: effects of Na+ transport inhibitors. Am J Physiol Renal Physiol 2016; 311: F1217-29.
Ow CPC, Ngo JP, Ullah MM, Hilliard LM, Evans RG. Renal hypoxia in kidney disease: cause or consequence? Acta Physiol (Oxf) 2018. DOI: https://doi.org/10.1111/apha.12999.
Tsui AK, Marsden PA, Mazer CD, et al. Differential HIF and NOS responses to acute anemia: defining organ-specific hemoglobin thresholds for tissue hypoxia. Am J Physiol Regul Integr Comp Physiol 2014; 307: R13-25.
Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-81.
Hare GM, Worrall JM, Baker AJ, Liu E, Sikich N, Mazer CD. Beta2 adrenergic antagonist inhibits cerebral cortical oxygen delivery after severe haemodilution in rats. Br J Anaesth 2006; 97: 617-23.
Hu T, Beattie WS, Mazer CD, et al. Treatment with a highly selective β-antagonist causes dose-dependent impairment of cerebral perfusion after hemodilution in rats. Anesth Analg 2013; 116: 649-62.
Ragoonanan TE, Beattie WS, Mazer CD, et al. Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology 2009; 111: 988-1000.
Ashes C, Judelman S, Wijeysundera DN, et al. Selective β1-antagonism with bisoprolol is associated with fewer postoperative strokes than atenolol or metoprolol: a single-center cohort study of 44,092 consecutive patients. Anesthesiology 2013; 119: 777-87.
Hare GM, Mazer CD, Hutchison JS, et al. Severe hemodilutional anemia increases cerebral tissue injury following acute neurotrauma. J Appl Physiol 1985; 2007(103): 1021-9.
McCredie VA, Piva S, Santos M, et al. The impact of red blood cell transfusion on cerebral tissue oxygen saturation in severe traumatic brain injury. Neurocrit Care 2017; 26: 247-55.
Okonkwo DO, Shutter LA, Moore C, et al. Brain oxygen optimization in severe traumatic brain injury phase-II: a phase ii randomized trial. Crit Care Med 2017; 45: 1907-14.
Zarychanski R, Abou-Setta AM, Turgeon AF, et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013; 309: 678-88.
Hare GM, Han K, Leshchyshyn Y, et al. Potential biomarkers of tissue hypoxia during acute hemodilutional anemia in cardiac surgery: a prospective study to assess tissue hypoxia as a mechanism of organ injury. Can J Anesth 2018; 65: 901-13.
Author contributions
Kyle Chin, Melina P. Cazorla-Bak, David F. Wilson, Sergei A. Vinogradov, Richard E. Gilbert, Kim A. Connelly, Roger G. Evans, Andrew J. Baker, C. David Mazer, and Gregory M.T. Hare contributed to all aspects of this manuscript, including study conception and design; acquisition, analysis, and interpretation of data; and drafting the article. Elaine Liu, Linda Nghiem, Yanling Zhang, and Julie Yu contributed to the conception and design of the study, acquisition and interpretation of data, preparation of figures, and drafting the article.
Disclosures
None.
Funding
Support for this study was provided by the Innovation Fund, St. Michael’s Hospital (to G.M.T. Hare), University of Toronto Merit Awards (to A.J. Baker, C.D. Mazer, K.A. Connelly and G.M.T. Hare). R.E. Gilbert holds a Canada Research Chair and this study was made possible by the Canada Research Chair’s fund.
Editorial responsibility
This submission was handled by Dr. Gregory L. Bryson, Deputy Editor-in-Chief, Canadian Journal of Anesthesia.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chin, K., Cazorla-Bak, M.P., Liu, E. et al. Renal microvascular oxygen tension during hyperoxia and acute hemodilution assessed by phosphorescence quenching and excitation with blue and red light. Can J Anesth/J Can Anesth 68, 214–225 (2021). https://doi.org/10.1007/s12630-020-01848-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12630-020-01848-5